The risk version of the MTNR1B gene (which codes for a melatonin receptor) has been associated with type II diabetes (T2D) and associated physiological markers. People with the risk version of the gene have reduced secretion of insulin when melatonin levels are high (between evening and morning) and impaired glucose tolerance when they eat late. Previous research suggests eating a protein enriched breakfast can improve glucose response. Therefore, the present study will investigate if the version of the MTNR1B gene that people have is associated with their glucose response after breakfast. Also, whether a protein enriched breakfast improves glucose response in participants with the risk version of the gene. Measures of glucose response collected over the two-week duration of the study will be compared between groups with the different versions of the gene. These findings can be used to provide personalised nutrition advice which may reduce the risk of T2D.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
60
Breakfast in one condition will be high carbohydrate and in the other protein enriched
St Mary's University
London, United Kingdom
Glucose response
Area under the curve
Time frame: 120 minutes
CGM metrics - mean glucose
mean glucose for 14 days measured using (FreeStyle Libre Pro iQ Continuous Glucose Monitoring System)
Time frame: 14 days
CGM metrics - Time in range
Time in range for 14 day period (FreeStyle Libre Pro iQ Continuous Glucose Monitoring System)
Time frame: 14 days
CGM metrics - glycaemic variability
glycaemic variability for 14 day period (FreeStyle Libre Pro iQ Continuous Glucose Monitoring System)
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.